Open AccessPotential need for expanded pharmacologic treatment and lifestyle modification services under the 2017 ACC/AHA Hypertension Guideline
Author(s) -
Ritchey Matthew D.,
Gillespie Cathleen,
Wozniak Gregory,
Shay Christina M.,
ThompsonPaul Angela M.,
Loustalot Fleetwood,
Hong Yuling
Publication year - 2018
Publication title -
the journal of clinical hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 67
eISSN - 1751-7176
pISSN - 1524-6175
DOI - 10.1111/jch.13364
Subject(s) - medicine , guideline , lifestyle modification , underweight , blood pressure , population , young adult , medline , physical therapy , gerontology , body mass index , obesity , environmental health , overweight , pathology , political science , law
Application of the 2017 ACC/AHA Hypertension Guideline expands the number of US adults requiring blood pressure (BP) management. The authors use 2011‐2014 NHANES data to describe the population groups most affected by the new guideline, compared with the previous JNC‐7 guideline, and describe the previous interaction with the health care sector among those adults recommended new or intensified pharmacologic treatment and/or lifestyle modification. The 2017 Hypertension Guideline reclassifies 32.3 million US adults as newly hypertensive and recommends BP‐related treatment of 133.7 million adults, including 57.8 million with uncontrolled BP recommended to initiate or intensify pharmacologic treatment and 50.5 million newly recommended lifestyle modification alone. An estimated 13.1 million (22.7%) adults recommended to initiate or intensify pharmacologic treatment, and 20.6 million (40.8%) adults newly recommended lifestyle modification alone report not having established health care linkages. Among the adults newly recommended lifestyle modification alone, the odds of reclassification from no recommended intervention, under JNC‐7, to recommended lifestyle modification alone were lower for adults with established linkages to care (aOR: 0.78 [95% CI: 0.67‐0.91]) compared to those without, decreased with increasing age, were greater for men (1.72 [1.52‐1.94]) compared to women and were greater for obese adults (1.23 [1.00‐1.53]) compared with normal or underweight adults. Application of the 2017 Hypertension Guideline increases the number and alters the distribution of US adults in need of initiating or intensifying BP treatment. This includes identifying millions of US adults who previously had limited interaction with health care and are now recommended new or intensified pharmacologic treatment and/or lifestyle modification.